Non-Current Assets
Total Assets
Gilead Sciences Total Assets decreased by 4.7% to $56.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.3%, from $56.43B to $56.28B. Over 5 years (FY 2020 to FY 2025), Total Assets shows a downward trend with a -2.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase suggests asset growth through investment or acquisition, while a decrease may indicate asset divestiture or depreciation.
Detailed definition
Total assets represent the aggregate value of all current and non-current resources owned by the company, including cash...
Peer comparison
Standard across all industries; peers in the pharmaceutical sector typically show high intangible asset ratios.
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.98B | $67.10B | $67.95B | $63.08B | $62.87B | $62.56B | $63.17B | $61.88B | $62.34B | $62.37B | $62.13B | $56.29B | $53.58B | $54.53B | $59.00B | $56.43B | $55.72B | $58.53B | $59.02B | $56.28B |
| QoQ Change | — | -1.3% | +1.3% | -7.2% | -0.3% | -0.5% | +1.0% | -2.0% | +0.7% | +0.1% | -0.4% | -9.4% | -4.8% | +1.8% | +8.2% | -4.3% | -1.3% | +5.0% | +0.8% | -4.7% |
| YoY Change | — | — | — | — | -7.5% | -6.8% | -7.0% | -1.9% | -0.8% | -0.3% | -1.7% | -9.0% | -14.0% | -12.6% | -5.0% | +0.3% | +4.0% | +7.4% | +0.0% | -0.3% |
Range$53.58B – $67.98B
CAGR-3.9%
Avg YoY Growth-3.5%
Median YoY Growth-1.8%
Total Assets at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's total assets?
- Gilead Sciences (GILD) reported total assets of $56.28B in Q1 2026.
- How has Gilead Sciences's total assets changed year-over-year?
- Gilead Sciences's total assets decreased by 0.3% year-over-year, from $56.43B to $56.28B.
- What is the long-term trend for Gilead Sciences's total assets?
- Over 5 years (2020 to 2025), Gilead Sciences's total assets has grown at a -2.9% compound annual growth rate (CAGR), from $68.41B to $59.02B.
- What does total assets mean?
- The total value of everything the company owns.